Management of hyperglycemia in a hospitalized patient with diabetes mellitus and cardiovascular disease

Joel Papak, Devan Kansagara

Research output: Contribution to journalArticle

9 Scopus citations

Abstract

Hyperglycemia in patients with and without known diabetes is a common finding in patients hospitalized with cardiovascular disease, and is associated with poor outcomes. Investigators have been examining the role of insulin to treat patients with acute myocardial infarction since the 1960's. Until the 1990's most studies evaluated fixed doses of glucose-insulin-potassium (GIK) infusions. The Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) trial, published in 1995, evaluated the role of adjustable-dose insulin infusion to lower blood glucose. Its promising results spurred further interest and a number of trials evaluating the use of insulin to lower blood glucose in hospitalized patients - many of which included patients with cardiovascular disease - have been conducted over the last two decades with conflicting results. This manuscript reviews the epidemiology and pathophysiology of hyperglycemia in hospitalized patients, summarizes the evidence for benefits and harms of using insulin to treat hyperglycemic patients hospitalized with cardiovascular disease, and offers some practical management considerations.

Original languageEnglish (US)
Pages (from-to)24B-31B
JournalAmerican Journal of Cardiology
Volume110
Issue numberSUPPL. 9
DOIs
StatePublished - Nov 6 2012

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Management of hyperglycemia in a hospitalized patient with diabetes mellitus and cardiovascular disease'. Together they form a unique fingerprint.

  • Cite this